Sign In
Buy LMAT
$91.64
+0.0200 (+0.0218%)
At Close: Jun 03, 2026
LeMaitre: Continues To Create Value, Breakout To New Highs
10:14am, Wednesday, 14'th Jun 2023
LeMaitre continues to add value for shareholders on multiple fronts. The company's business economics support earnings and dividend growth. Looking ahead, the company could be worth $85 intrinsic valu
Why The Best Dividend Stocks Are Hated By Analysts
07:30am, Thursday, 08'th Jun 2023
Analyst ratings are a wonderful contrarian indicator.
LeMaitre to Present at Upcoming Investor Conferences in June
05:15pm, Tuesday, 06'th Jun 2023
BURLINGTON, Mass., June 06, 2023 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it is participating in two upcoming investor conferences in June.
LeMaitre (LMAT) Upgraded to Strong Buy: Here's Why
01:01pm, Wednesday, 31'st May 2023
LeMaitre (LMAT) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Best Momentum Stocks to Buy for May 23rd
11:08am, Tuesday, 23'rd May 2023
ONON, PKOH and LMAT made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on May 23, 2023.
Is This Healthcare Stock a Buy for Dividend Growth Investors?
10:07am, Wednesday, 17'th May 2023
LeMaitre Vascular logged impressive sales growth in the first quarter. The company could maintain outsize payout growth in the future.
What Makes LeMaitre Vascular (LMAT) a Strong Momentum Stock: Buy Now?
01:41pm, Wednesday, 10'th May 2023
Does LeMaitre Vascular (LMAT) have what it takes to be a top stock pick for momentum investors? Let's find out.
Why Shares of LeMaitre Vascular Are Up Wednesday
01:56pm, Wednesday, 03'rd May 2023
LeMaitre credited a beefed-up sales force and an uptick in hospital orders for higher numbers. The company grew revenue by 19% year over year in the first quarter.
LeMaitre Vascular, Inc. (LMAT) Q1 2023 Earnings Call Transcript
10:10pm, Tuesday, 02'nd May 2023
LeMaitre Vascular, Inc. (NASDAQ:LMAT ) Q1 2023 Earnings Conference Call May 2, 2023 5:00 PM ET Company Participants Joseph Pellegrino - Chief Financial Officer George LeMaitre - Chairman and Chief Exe
ZBH or LMAT: Which Is the Better Value Stock Right Now?
12:54pm, Wednesday, 26'th Apr 2023
Investors with an interest in Medical - Products stocks have likely encountered both Zimmer Biomet (ZBH) and LeMaitre Vascular (LMAT). But which of these two stocks offers value investors a better ban
Income Investors: These 2 Stocks Have Quadrupled Their Dividend Payouts Over the Past 10 Years
05:44am, Thursday, 06'th Apr 2023
Amgen and LeMaitre Vascular both possess solid product portfolios and pipelines to drive future earnings growth. Their payouts are well-covered by their earnings.
ZBH vs. LMAT: Which Stock Is the Better Value Option?
12:58pm, Tuesday, 28'th Mar 2023
ZBH vs. LMAT: Which Stock Is the Better Value Option?
Buy This Under-the-Radar Stock for Dividend Growth
07:10am, Saturday, 11'th Mar 2023
LeMaitre Vascular's results were mixed in the fourth quarter. The company could maintain high dividend growth moving forward.
LeMaitre to Participate at Upcoming Investor Conferences in March
02:26pm, Friday, 03'rd Mar 2023
BURLINGTON, Mass., March 03, 2023 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that management will be participating in four upcoming investor conferences in March.
LeMaitre: Remaining Constructive On Long-Term Valuations
04:44am, Friday, 03'rd Mar 2023
Reasonable growth vertically throughout P&L and cash flows, exhibiting strength in major markets. Growth in rep headcount converting at the top line looks to further growth in reps in FY23.
